Status:
WITHDRAWN
Standardized Protocol of Surgery and Radiation for Patients With Brain Metastases in Relapsed Neuroblastoma
Lead Sponsor:
Giselle Sholler
Conditions:
Relapsed Neuroblastoma
Eligibility:
All Genders
Up to 21 years
Phase:
NA
Brief Summary
HITC001 is a single institution study to evaluate the efficacy of using a standardized protocol of surgery and radiation for patients with brain metastases in relapsed neuroblastoma.
Detailed Description
This clinical trial aims to establish a standardized protocol consisting of surgery and radiation for patients with brain metastases in relapsed neuroblastoma. This will be an adjunct study to NMTRC00...
Eligibility Criteria
Inclusion
- Age: ≤ 21 years at the time of study entry.
- Diagnosis: Histologic verification at either the time of original diagnosis or relapse of neuroblastoma.
- Disease Status: Patients must have ONE of the following along with disease in the CNS:
- Any episode of recurrent disease following completion of aggressive multi-drug frontline therapy.
- Any episode of progressive disease during aggressive multi-drug frontline therapy.
- Primary resistant/refractory disease detected at the conclusion of at least 4 cycles of aggressive multidrug induction chemotherapy on or according to a high-risk neuroblastoma protocols.
- Measurable or evaluable disease by Brain MRI.
- Current disease state must be one for which there is currently no known curative therapy.
- Meet all inclusion criteria for study NMTRC009
- Informed Consent: All subjects and/or legal guardians must sign informed written consent. Assent, when appropriate, will be obtained according to institutional guidelines
Exclusion
- Meets all exclusion criteria for study NMTRC009
- Subjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 11 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03406273
Start Date
May 1 2017
End Date
December 11 2019
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helen DeVos Children's Hospital
Grand Rapids, Michigan, United States, 49503